Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) CEO Jitendra Mohan sold 96,089 shares of the business’s stock in a transaction dated Monday, November 16th. The shares were sold at an average price of $206.62, for a total transaction of $19,853,909.18. Following the transaction, the chief executive officer owned 1,170,576 shares in the company, valued at $241,864,413.12. This represents a 7.59% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Astera Labs Price Performance
ALAB stock opened at $216.75 on Thursday. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48. The company has a market cap of $37.88 billion, a P/E ratio of 86.35 and a beta of 3.85. The firm has a 50-day moving average of $288.88 and a 200 day moving average of $257.84.
Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its quarterly earnings data on Tuesday, November 3rd. The company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.19 by $0.13. The business had revenue of $584.90 million during the quarter, compared to analyst estimates of $550.78 million. Astera Labs had a net margin of 29.64% and a return on equity of 25.35%. Astera Labs’s quarterly revenue was up 153.6% compared to the same quarter last year. During the same period last year, the business posted $0.49 earnings per share. On average, equities research analysts expect that Astera Labs, Inc. will post 2.99 earnings per share for the current fiscal year.
Institutional Trading of Astera Labs
Several institutional investors have recently bought and sold shares of ALAB. Liontrust Investment Partners LLP raised its holdings in Astera Labs by 117.7% in the third quarter. Liontrust Investment Partners LLP now owns 67,504 shares of the company’s stock worth $24,029,000 after buying an additional 36,490 shares during the last quarter. Zacks Investment Management bought a new position in shares of Astera Labs in the third quarter worth approximately $3,013,000. Kentucky Retirement Systems Insurance Trust Fund bought a new position in shares of Astera Labs in the third quarter worth approximately $1,389,000. Kentucky Retirement Systems purchased a new stake in shares of Astera Labs during the third quarter valued at approximately $3,431,000. Finally, Algert Global LLC grew its holdings in shares of Astera Labs by 1,447.7% during the third quarter. Algert Global LLC now owns 9,936 shares of the company’s stock valued at $3,537,000 after buying an additional 9,294 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.
Key Stories Impacting Astera Labs
These are some of the ALAB stories that stood out recently:
- Positive Sentiment: Astera Labs expanded its partnership with Hyve Solutions, whose Apex platform will incorporate Astera’s Orion Compute Board, Fabric Tray and Link Board. The pre-validated components are intended to speed AI-rack integration for enterprise and neocloud customers and accommodate future, higher-power accelerators. Article: How Does Astera Labs’ New AI Infrastructure Partnership Change Its Enterprise Opportunity?
- Negative Sentiment: Recent coverage describes a shaky rebound, weaker market momentum and analyst price-target resets. ALAB also remains below its 50-day and 200-day moving averages, suggesting technical pressure may persist. Article: Record Q3 Growth Meets a Shaky Rebound
- Negative Sentiment: ETFs were reported as net sellers of ALAB, adding a potential source of near-term selling pressure. Article: ETFs Are Net Sellers of Astera Labs
Analysts Set New Price Targets
A number of research analysts have recently commented on the company. Jefferies Financial Group raised their target price on Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Wall Street Zen raised Astera Labs from a “hold” rating to a “buy” rating in a research note on Saturday, November 7th. Northland Securities raised Astera Labs from a “market perform” rating to an “outperform” rating and set a $315.00 price target on the stock in a research note on Wednesday, November 4th. Zacks Research downgraded Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. Finally, Morgan Stanley increased their price objective on Astera Labs from $382.00 to $389.00 and gave the stock an “overweight” rating in a report on Wednesday, November 4th. Thirteen equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $320.85.
Read Our Latest Stock Report on Astera Labs
Astera Labs Company Profile
Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.
Featured Articles
- Five stocks we like better than Astera Labs
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
